Search Results - "SALMON, P"

Alzheimer's Disease: Past, Present, and Future by Bondi, Mark W, Edmonds, Emily C, Salmon, David P

“…Although dementia has been described in ancient texts over many centuries (e.g., "Be kind to your father, even if his mind fail him." - Old Testament: Sirach…”
Get more information

Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: a review of 20 years of research by Boublay, N., Schott, A. M., Krolak-Salmon, P.

“…Assessing morphological, perfusion and metabolic brain changes preceding or associated with neuropsychiatric symptoms (NPSs) will help in the understanding of…”
Get full text

Age-related increase in mitochondrial quantity may mitigate a decline in mitochondrial quality in red blood cells from zebra finches (Taeniopygia guttata) by Dawson, N.J., Salmón, P.

“…Aging is typically associated with a decline in whole animal performance that ultimately contributes to death. It is suspected that a decline in ATP production…”
Get full text

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change by Smirnov, Denis S., Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik, Simrén, Joel, Lantero-Rodriguez, Juan, Karikari, Thomas K., Hiniker, Annie, Rissman, Robert A., Salmon, David P., Galasko, Douglas

“…Plasma biomarkers related to amyloid, tau, and neurodegeneration (ATN) show great promise for identifying these pathological features of Alzheimer’s Disease…”
Get full text

State-of-science: situation awareness in individuals, teams and systems by Stanton, N. A., Salmon, P. M., Walker, G. H., Salas, E., Hancock, P. A.

“…Our review addresses one of the most used, but debated, topics in Ergonomics: Situation Awareness (SA). We examine and elaborate upon key SA models. These…”
Get full text

The neuropsychological profile of Alzheimer disease by Weintraub, Sandra, Wicklund, Alissa H, Salmon, David P

“…Neuropsychological assessment has featured prominently over the past 30 years in the characterization of dementia associated with Alzheimer disease (AD)…”
Get full text

The A4 study: stopping AD before symptoms begin? by Sperling, Reisa A, Rentz, Dorene M, Johnson, Keith A, Karlawish, Jason, Donohue, Michael, Salmon, David P, Aisen, Paul

“…A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer's disease dementia should provide insights into whether…”
Get more information

Neuropsychological Assessment of Dementia by SALMON, David P, BONDI, Mark W

“…Neuropsychological studies show that cognitive deficits associated with Alzheimer's disease (AD) are distinct from age-associated cognitive decline…”
Get full text

Complexity and systems thinking in sport by McLean, S, Robertson, S, Salmon, P M

Get full text

Prodromal or mild Alzheimer's disease: Influence of neuropsychiatric symptoms and premordid personality on caregivers' burden by Dorey, J. M., Pongan, E., Padovan, C., Chaillet, A., Herrmann, M., Krolak‐Salmon, P., Rouch, I.

“…Objective In Alzheimer's disease (AD), the burden on caregivers is influenced by various factors, including the stage of disease progression and…”
Get full text

The driver, the road, the rules … and the rest? A systems-based approach to young driver road safety by Scott-Parker, B., Goode, N., Salmon, P.

“…•Many factors play a role in young driver safety, in addition to individual risk factors.•A driver-centric approach has been prevalent in young driver safety…”
Get full text

Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment by Edmonds, Emily C, Delano-Wood, Lisa, Galasko, Douglas R, Salmon, David P, Bondi, Mark W

“…Subjective cognitive complaints are a criterion for the diagnosis of mild cognitive impairment (MCI), despite their uncertain relationship to objective memory…”
Get more information

Early versus late MCI: Improved MCI staging using a neuropsychological approach by Edmonds, Emily C., McDonald, Carrie R., Marshall, Anisa, Thomas, Kelsey R., Eppig, Joel, Weigand, Alexandra J., Delano-Wood, Lisa, Galasko, Douglas R., Salmon, David P., Bondi, Mark W.

“…The Alzheimer's Disease Neuroimaging Initiative (ADNI) separates “early” and “late” mild cognitive impairment (MCI) based on a single memory test. We compared…”
Get full text

Effect of Knowledge of APOE Genotype on Subjective and Objective Memory Performance in Healthy Older Adults by Lineweaver, Tara T., Bondi, Mark W., Galasko, Douglas, Salmon, David P.

“…Older adults who know they have the e4 allele of the apolipoprotein E (APOE) gene, a risk factor for Alzheimer’s disease, perform worse on objective tests of…”
Get full text

Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors by Edmonds, Emily C, Delano-Wood, Lisa, Clark, Lindsay R, Jak, Amy J, Nation, Daniel A, McDonald, Carrie R, Libon, David J, Au, Rhoda, Galasko, Douglas, Salmon, David P, Bondi, Mark W

“…Abstract Background We assessed whether mild cognitive impairment (MCI) subtypes could be empirically derived within the Alzheimer's Disease Neuroimaging…”
Get full text

TDP‐43 Pathology Exacerbates Cognitive Decline in Primary Age‐Related Tauopathy by Smirnov, Denis S., Salmon, David P., Galasko, Douglas, Edland, Steven D., Pizzo, Donald P., Goodwill, Vanessa, Hiniker, Annie

“…Objective Primary age‐related tauopathy (PART) refers to tau neurofibrillary tangles restricted largely to the medial temporal lobe in the absence of…”
Get full text

How to explore the needs of informal caregivers of individuals with cognitive impairment in Alzheimer's disease or related diseases? A systematic review of quantitative and qualitative studies by Novais, T, Dauphinot, V, Krolak-Salmon, P, Mouchoux, C

“…This study aims to review the methodologies used to identify the needs, the existing needs assessment instruments and the main topics of needs explored among…”
Get full text

Vitamin D insufficiency and mild cognitive impairment: cross-sectional association by Annweiler, C., Fantino, B., Schott, A. M., Krolak-Salmon, P., Allali, G., Beauchet, O.

“…Background:  Low serum 25‐hydroxyvitamin D (25OHD) concentrations have been associated with dementia. The association with mild cognitive impairment (MCI) has…”
Get full text

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease by Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin, Vahlsing, H Lee, Ho, Gilbert, Tong, Gang, Potkin, Steven G, Fallon, James, Hansen, Lawrence, Mufson, Elliott J, Kordower, Jeffrey H, Gall, Christine, Conner, James

“…Cholinergic neuron loss is a cardinal feature of Alzheimer disease. Nerve growth factor (NGF) stimulates cholinergic function, improves memory and prevents…”
Get full text

Specificities of acute phase stroke management in the elderly by Smadja, D., Krolak-Salmon, P.

“…Health professionals are currently facing the challenge of managing an increasing number of old patients presenting with acute stroke, due to rapid aging of…”
Get full text